Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
editorial
. 1993 Aug;53(2):301–304.

Genotype, malleotype, phenotype, and randomness: lessons from neurofibromatosis-1 (NF-1)

V M Riccardi
PMCID: PMC1682332  PMID: 8328448

Full text

PDF
301

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allanson J. E., Upadhyaya M., Watson G. H., Partington M., MacKenzie A., Lahey D., MacLeod H., Sarfarazi M., Broadhead W., Harper P. S. Watson syndrome: is it a subtype of type 1 neurofibromatosis? J Med Genet. 1991 Nov;28(11):752–756. doi: 10.1136/jmg.28.11.752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barlow D. P. Methylation and imprinting: from host defense to gene regulation? Science. 1993 Apr 16;260(5106):309–310. doi: 10.1126/science.8469984. [DOI] [PubMed] [Google Scholar]
  3. Caskey C. T., Pizzuti A., Fu Y. H., Fenwick R. G., Jr, Nelson D. L. Triplet repeat mutations in human disease. Science. 1992 May 8;256(5058):784–789. doi: 10.1126/science.1589758. [DOI] [PubMed] [Google Scholar]
  4. Chao L. Y., Huff V., Tomlinson G., Riccardi V. M., Strong L. C., Saunders G. F. Genetic mosaicism in normal tissues of Wilms' tumour patients. Nat Genet. 1993 Feb;3(2):127–131. doi: 10.1038/ng0293-127. [DOI] [PubMed] [Google Scholar]
  5. Easton D. F., Ponder M. A., Huson S. M., Ponder B. A. An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. Am J Hum Genet. 1993 Aug;53(2):305–313. [PMC free article] [PubMed] [Google Scholar]
  6. Edwards J. H. Familiarity, recessivity and germline mosaicism. Ann Hum Genet. 1989 Jan;53(Pt 1):33–47. doi: 10.1111/j.1469-1809.1989.tb01120.x. [DOI] [PubMed] [Google Scholar]
  7. Kayes L. M., Riccardi V. M., Burke W., Bennett R. L., Stephens K. Large de novo DNA deletion in a patient with sporadic neurofibromatosis 1, mental retardation, and dysmorphism. J Med Genet. 1992 Oct;29(10):686–690. doi: 10.1136/jmg.29.10.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Rey J. A., Bello M. J., de Campos J. M., Vaquero J., Kusak M. E., Sarasa J. L., Pestaña A. Abnormalities of chromosome 22 in human brain tumors determined by combined cytogenetic and molecular genetic approaches. Cancer Genet Cytogenet. 1993 Mar;66(1):1–10. doi: 10.1016/0165-4608(93)90140-h. [DOI] [PubMed] [Google Scholar]
  9. Riccardi V. M., Lewis R. A. Penetrance of von Recklinghausen neurofibromatosis: a distinction between predecessors and descendants. Am J Hum Genet. 1988 Feb;42(2):284–289. [PMC free article] [PubMed] [Google Scholar]
  10. Riccardi V. M. Neurofibromatosis: clinical heterogeneity. Curr Probl Cancer. 1982 Aug;7(2):1–34. doi: 10.1016/s0147-0272(82)80016-0. [DOI] [PubMed] [Google Scholar]
  11. Smits A., Smeets D., Dreesen J., Hamel B., de Haan A., van Oost B. Parental origin of the fra(X) gene is a major determinant of the cytogenetic expression and the CGG repeat length in female carriers. 1992 Apr 15-May 1Am J Med Genet. 43(1-2):261–267. doi: 10.1002/ajmg.1320430141. [DOI] [PubMed] [Google Scholar]
  12. Trofatter J. A., MacCollin M. M., Rutter J. L., Murrell J. R., Duyao M. P., Parry D. M., Eldridge R., Kley N., Menon A. G., Pulaski K. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell. 1993 Mar 12;72(5):791–800. doi: 10.1016/0092-8674(93)90406-g. [DOI] [PubMed] [Google Scholar]
  13. Wallace M. R., Marchuk D. A., Andersen L. B., Letcher R., Odeh H. M., Saulino A. M., Fountain J. W., Brereton A., Nicholson J., Mitchell A. L. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science. 1990 Jul 13;249(4965):181–186. doi: 10.1126/science.2134734. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES